Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis  Dr. Falk Pharma GmbH, a research-based pharmaceutical company specializing in digestive and

Ambiq Announces Pricing of Initial Public Offering Ambiq Announces Pricing of Initial Public Offering AUSTIN, Texas, July 29, 2025 (GLOBE NEWSWIRE) — Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the pricing of its upsized initial public offering of 4,000,000 shares of

Platinum partner in IBM Partner Plus; Plans to collaborate on AI adoption across industries BEAVERTON, Ore., July 30, 2025 (GLOBE NEWSWIRE) — via IBN – Datavault AI Inc. (Nasdaq: DVLT), a leader in AI data experience, valuation, and monetization, today announced the expanded commercialization of its flagship AI agents—DataScore® and